This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wallace, J. M. Search for Related Content PubMed PubMed Citation Articles by Wallace, J. M. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Cancer Social Bookmarking                         What's this?

Nutritional and Botanical Modulation of the Inflammatory Cascade—Eicosanoids, Cyclooxygenases, and Lipoxygenases— As an Adjunct in Cancer Therapy

Emerging on the horizon in cancer therapy is an expansion of the scope of treatment beyond cytotoxic approaches to in clude molecular management of cancer physiopathology. The goal in these integrative approaches, which extends beyond eradicating the affected cells, is to control the cancer phenotype. One key new approach appears to be modulation of the inflammatory cascade, as research is expanding that links cancer initiation, promotion, progression, angiogenesis, and metastasis to inflammatory events. This article presents a literature review of the emerging relation ship between neoplasia and inflammatory eicosanoids (PGE2 and related prostaglandins), with a focus on how inhibition of their synthesizing oxidases, particularly cyclooxygenase (COX), offers anticancer actions in vitro and in vivo. Although a majority of this research emphasizes the pharmaceutical applications of nonsteroidal anti-inflammatory drugs and selective COX-2 inhibitors, these agents fail to address alternate pathways available for the synthesis of proinflammatory eicosanoids. Evidence is presented that sug gests the inhibition of lipoxygenase and its by-products— LTB4, 5-HETE, and 12—HETE—represents an overlooked but crucial component in complementary cancer therapies. Based on the hypothesis that natural agents capable of modulating both lipoxygenase and COX may advance the efficacy of cancer therapy, an overview and discussion is presented of dietary modifications and selected nutritional and botanical agents (notably, omega-3 fatty acids, andoxi dants, boswellia, bromelain, curcumin, and quercetin) that favorably influence eicosanoid production.

Integrative Cancer Therapies, Vol. 1, No. 1, 7-37 (2002)
DOI: 10.1177/153473540200100102


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				K. I. Block, P. B. Block, S. Reynolds Fox, J. Stouffer Birris, A. Y. Feng, M. de la Torre, D. Nathan, P. Tothy, A. K. Maki, and C. Gyllenhaal Making Circadian Cancer Therapy Practical Integr Cancer Ther, December 1, 2009; 8(4): 371 - 386. [Abstract] [PDF]

				S. Jain, G. Chakraborty, R. Raja, S. Kale, and G. C. Kundu Prostaglandin E2 Regulates Tumor Angiogenesis in Prostate Cancer Cancer Res., October 1, 2008; 68(19): 7750 - 7759. [Abstract] [Full Text] [PDF]

				J. T. Mao, D. P. Tashkin, I-H. Tsu, and K. J. Serio Differential Modulation of Leukotriene B4 Synthesis and Degradation in Human Bronchoalveolar Lavage Cells by Lipopolysaccharide and Tobacco Smoke Cancer Prevention Research, September 1, 2008; 1(4): 266 - 274. [Abstract] [Full Text] [PDF]

				I. A. Butovich and S. M. Lukyanova Inhibition of lipoxygenases and cyclooxygenases by linoleyl hydroxamic acid: comparative in vitro studies J. Lipid Res., June 1, 2008; 49(6): 1284 - 1294. [Abstract] [Full Text] [PDF]

				Y. G. Lin, A. B. Kunnumakkara, A. Nair, W. M. Merritt, L. Y. Han, G. N. Armaiz-Pena, A. A. Kamat, W. A. Spannuth, D. M. Gershenson, S. K. Lutgendorf, et al. Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-{kappa}B Pathway Clin. Cancer Res., June 1, 2007; 13(11): 3423 - 3430. [Abstract] [Full Text] [PDF]

				N. Kobayashi, R. J. Barnard, S. M. Henning, D. Elashoff, S. T. Reddy, P. Cohen, P. Leung, J. Hong-Gonzalez, S. J. Freedland, J. Said, et al. Effect of Altering Dietary {omega}-6/{omega}-3 Fatty Acid Ratios on Prostate Cancer Membrane Composition, Cyclooxygenase-2, and Prostaglandin E2 Clin. Cancer Res., August 1, 2006; 12(15): 4662 - 4670. [Abstract] [Full Text] [PDF]

				S. Jain, G. Chakraborty, and G. C. Kundu The Crucial Role of Cyclooxygenase-2 in Osteopontin-Induced Protein Kinase C {alpha}/c-Src/I{kappa}B Kinase {alpha}/{beta}-Dependent Prostate Tumor Progression and Angiogenesis. Cancer Res., July 1, 2006; 66(13): 6638 - 6648. [Abstract] [Full Text] [PDF]

				T. Kaczor Naturopathy Integr Cancer Ther, June 1, 2006; 5(2): 140 - 147. [PDF]

				D. R. Yance Jr and S. M. Sagar Targeting Angiogenesis With Integrative Cancer Therapies Integr Cancer Ther, March 1, 2006; 5(1): 9 - 29. [Abstract] [PDF]

				S. Bengmark Curcumin, An Atoxic Antioxidant and Natural NF{kappa}B, Cyclooxygenase-2, Lipooxygenase, and Inducible Nitric Oxide Synthase Inhibitor: A Shield Against Acute and Chronic Diseases JPEN J Parenter Enteral Nutr, January 1, 2006; 30(1): 45 - 51. [Abstract] [Full Text] [PDF]

				K. L. Fritsche Are Omega-3 Fatty Acids Effective in Enhancing Tumoricidal Cell Activity? J. Nutr., December 1, 2005; 135(12): 2916S - 2917S. [Full Text] [PDF]

				S. Ahmed, J. Anuntiyo, C. J. Malemud, and T. M. Haqqi Biological Basis for the Use of Botanicals in Osteoarthritis and Rheumatoid Arthritis: A Review Evid. Based Complement. Altern. Med., September 1, 2005; 2(3): 301 - 308. [Abstract] [Full Text] [PDF]

				R. Hammamieh, M. Anderson, K. Carr, C. N. Tran, D. L. Yourick, and M. Jett Students Investigating the Antiproliferative Effects of Synthesized Drugs on Mouse Mammary Tumor Cells CBE Life Sci Educ, September 1, 2005; 4(3): 221 - 234. [Abstract] [Full Text] [PDF]

				K. I. Block The Demise of the Super-aspirins: An Opportunity for Integrative Medicine? Integr Cancer Ther, March 1, 2005; 4(1): 5 - 7. [Abstract] [PDF]

				J. T. Mao, I-H. Tsu, S. M. Dubinett, B. Adams, T. Sarafian, F. Baratelli, M. D. Roth, and K. J. Serio Modulation of Pulmonary Leukotriene B4 Production by Cyclooxygenase-2 Inhibitors and Lipopolysaccharide Clin. Cancer Res., October 15, 2004; 10(20): 6872 - 6878. [Abstract] [Full Text] [PDF]

				K. I. Block Optimal Healing Environments and Integrative Cancer Therapy Integr Cancer Ther, June 1, 2004; 3(2): 95 - 97. [PDF]

				J. M. Wallace Integrative Tumor Board: Glioblastoma Multiforme: Nutritional and Botanical Approach Integr Cancer Ther, June 1, 2004; 3(2): 152 - 163. [PDF]